Abstract:Chondrocytes proliferate and mature into hypertrophic chondrocytes. Vascular invasion into the cartilage occurs in the terminal hypertrophic chondrocyte layer, and terminal hypertrophic chondrocytes die by apoptosis or transdifferentiate into osteoblasts. Runx2 is essential for osteoblast differentiation and chondrocyte maturation. Runx2 -deficient mice are composed of cartilaginous skeletons and lack the vascular invasion into the cartilage. However, the requirement of Runx2 in the vascular invasion into the cartilage, mechanism of chondrocyte transdifferentiation to osteoblasts, and its significance in bone development remain to be elucidated. To investigate these points, we generated Runx2 fl/flCre mice, in which Runx2 was deleted in hypertrophic chondrocytes using Col10a1 Cre. Vascular invasion into the cartilage was similarly observed in Runx2 fl/fl and Runx2 fl/flCre mice. Vegfa expression was reduced in the terminal hypertrophic chondrocytes in Runx2 fl/flCre mice, but Vegfa was strongly expressed in osteoblasts in the bone collar, suggesting that Vegfa expression in bone collar osteoblasts is sufficient for vascular invasion into the cartilage. The apoptosis of terminal hypertrophic chondrocytes was increased and their transdifferentiation was interrupted in Runx2 fl/flCre mice, leading to lack of primary spongiosa and osteoblasts in the region at E16.5. The osteoblasts appeared in this region at E17.5 in the absence of transdifferentiation, and the number of osteoblasts and the formation of primary spongiosa, but not secondary spongiosa, reached to levels similar those in Runx2 fl/fl mice at birth. The bone structure and volume and all bone histomophometric parameters were similar between Runx2 fl/fl and Runx2 fl/flCre mice after 6 weeks of age. These findings indicate that Runx2 expression in terminal hypertrophic chondrocytes is not required for vascular invasion into the cartilage, but is for their survival and transdifferentiation into osteoblasts, and that the transdifferentiation is necessary for trabecular bone formation in embryonic and neonatal stages, but not for acquiring normal bone structure and volume in young and adult mice.

Advances in the Roles of Runt-Related Transcription Factor 2 in Skeletal Development and Differentiation of Mesenchymal Stem Cells

Runx2 and microRNA regulation in bone and cartilage diseases

Runt-related transcription factor 1 is required for murine osteoblast differentiation and bone formation

Regulation of Proliferation, Differentiation and Functions of Osteoblasts by Runx2

Molecular Mechanism of Runx2-Dependent Bone Development

[Latest Findings on the Role of RUNX1 in Bone Development and Disorders]

Effects of runt-related transcription factor 2 (RUNX2) on the autophagy of rapamycin-treated osteoblasts

"A Friend Among Strangers" or the Ambiguous Roles of Runx2

Runx2 is essential for the transdifferentiation of chondrocytes into osteoblasts

Runx2, an inducer of osteoblast and chondrocyte differentiation

TET Enzymes Regulate Skeletal Development Through Increasing Chromatin Accessibility of RUNX2 Target Genes

Runx2 Overexpression Enhances Osteoblastic Differentiation and Mineralization in Adipose - Derived Stem Cells in Vitro and in Vivo

Genetic analysis of Runx2 function during intramembranous ossification

RUNX3 in Stem Cell and Cancer Biology

Multiple Roles of Runt-related Transcription Factor-2 in Tooth Eruption: Bone Formation and Resorption.

RUNX2 Regulates Osteoblast Differentiation via the BMP4 Signaling Pathway

Functional Analyses Reveal the Essential Role of Sox6 and Runx2 in the Communication of Chondrocyte and Osteoblast

RUNX2 as a promising therapeutic target for malignant tumors

A RUNX2 stabilization pathway mediates physiologic and pathologic bone formation

Runt‐related transcription factor‐2 (Runx2) is required for bone matrix protein gene expression in committed osteoblasts in mice

The Unique Function of Runx1 in Skeletal Muscle Differentiation and Regeneration is Mediated by an ETS Interaction Domain